Literature DB >> 15215698

Chlamydia and gonorrhea co-occurrence in a high school population.

Malanda Nsuami1, Catherine L Cammarata, Bridget N Brooks, Stephanie N Taylor, David H Martin.   

Abstract

BACKGROUND: Chlamydia and gonorrhea coinfection outside of healthcare facilities is less well known. GOAL: To determine the co-occurrence of both sexually transmitted diseases (STDs) among high school students participating in a school-based screening and to assess the relevance of dual treatment recommendations in this population. STUDY
DESIGN: During the 1998 to 1999 school year, 5,877 students attending an urban U.S. school district were screened for chlamydia and gonorrhea using urine ligase chain reaction assays.
RESULTS: Overall, 451 students had chlamydia, 117 had gonorrhea, including 50 who had both STDs. The gonorrhea and chlamydia co-infections were 50/451 (11.1%) and 50/117 (42.7%), respectively. STD symptoms were reported by 16.0% of students having both infections, 7.7% of those having gonorrhea only, and 5.0% of students having chlamydia only (P = 0.01).
CONCLUSIONS: The rates of coinfection in this population exceeded those that justify dual treatment in patient-care settings. Chlamydia and gonorrhea co-occurrence may be highly prevalent among certain populations not attending patient-care settings.

Entities:  

Mesh:

Year:  2004        PMID: 15215698     DOI: 10.1097/01.olq.0000130535.96576.d3

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  8 in total

1.  Structural characterization of muropeptides from Chlamydia trachomatis peptidoglycan by mass spectrometry resolves "chlamydial anomaly".

Authors:  Mathanraj Packiam; Brian Weinrick; William R Jacobs; Anthony T Maurelli
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-19       Impact factor: 11.205

2.  Aptima Combo 2 testing detected additional cases of Neisseria gonorrhoeae infection in men and women in community settings.

Authors:  Julius Kapala; Kathy Biers; Michael Cox; Margaret Kamionka; Jeff Sumner; Ramandeep Toor; Jodi Gilchrist; Dan Jang; Marek Smieja; Max Chernesky
Journal:  J Clin Microbiol       Date:  2011-03-16       Impact factor: 5.948

3.  Risk of coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae in Nova Scotia.

Authors:  Kevin R Forward
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

4.  Chlamydial infection increases gonococcal colonization in a novel murine coinfection model.

Authors:  Rachel A Vonck; T Darville; C M O'Connell; Ann E Jerse
Journal:  Infect Immun       Date:  2011-01-18       Impact factor: 3.441

5.  Cost-effectiveness of screening strategies for Chlamydia trachomatis using cervical swabs, urine, and self-obtained vaginal swabs in a sexually transmitted disease clinic setting.

Authors:  Diane R Blake; Nancy Maldeis; Mathilda R Barnes; Andrew Hardick; Thomas C Quinn; Charlotte A Gaydos
Journal:  Sex Transm Dis       Date:  2008-07       Impact factor: 2.830

6.  Estradiol-Treated Female Mice as Surrogate Hosts for Neisseria gonorrhoeae Genital Tract Infections.

Authors:  Ann E Jerse; Hong Wu; Mathanraj Packiam; Rachel A Vonck; Afrin A Begum; Lotisha E Garvin
Journal:  Front Microbiol       Date:  2011-07-01       Impact factor: 5.640

7.  Biological feasibility and importance of a gonorrhea vaccine for global public health.

Authors:  Leah R Vincent; Ann E Jerse
Journal:  Vaccine       Date:  2018-04-18       Impact factor: 3.641

8.  Formulas for estimating the costs averted by sexually transmitted infection (STI) prevention programs in the United States.

Authors:  Harrell W Chesson; Dayne Collins; Kathryn Koski
Journal:  Cost Eff Resour Alloc       Date:  2008-05-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.